Home > > Global Veterinary AST Market Report
The Veterinary AST market was valued at $94.5 Million in 2022, and is projected to reach $167.9 Million by 2032 growing at a CAGR of 5.97% from 2023 to 2032.The veterinary AST (animal serum and tissue) market is driven by a number of factors, including the increasing demand for animal-derived products in the pharmaceutical, cosmetics, and food industries, as well as the growing awareness of the importance of animal health and welfare. Opportunities in the market include the development of new products and technologies, such as diagnostic kits and vaccines, as well as the expansion into emerging markets. Some of the top companies in the veterinary AST market include Thermo Fisher Scientific, Merck, Charles River Laboratories, and Bio-Rad Laboratories. These companies have made significant developments in recent years, such as the launch of new products and the expansion of their manufacturing and distribution capabilities.